2023
Pathologic concordance rate and outcomes by histologic subtype in advanced papillary renal cell (pRCC) carcinoma: An analysis from the SWOG S1500 (PAPMET) trial.
Tripathi A, Tangen C, Li X, Tretiakova M, Humphrey P, Adeniran A, Barata P, Gulati S, Bergerot C, Pruthi D, Thompson I, Lara P, Pal S, Shuch B. Pathologic concordance rate and outcomes by histologic subtype in advanced papillary renal cell (pRCC) carcinoma: An analysis from the SWOG S1500 (PAPMET) trial. Journal Of Clinical Oncology 2023, 41: 4562-4562. DOI: 10.1200/jco.2023.41.16_suppl.4562.Peer-Reviewed Original ResearchProgression-free survivalPositive predictive valueCentral pathology reviewCentral reviewPathology reviewHistologic subtypeType 1PRCC subtypesAdvanced papillary renal cell carcinomaPathologic concordance rateLines of therapyPapillary renal cell carcinomaSubset of patientsType 2 tumorGreater clinical benefitRenal cell carcinomaLimited clinical valueType 2 diseaseExpert genitourinary pathologistsLocal reviewClassification of subtypesSunitinib armMET alterationsClinical outcomesClinical benefit
2007
Segmental disorders of the nephron: histopathological and imaging perspective
Prasad S, Narra V, Shah R, Humphrey P, Jagirdar J, Catena J, Dalrymple N, Siegel C. Segmental disorders of the nephron: histopathological and imaging perspective. British Journal Of Radiology 2007, 80: 593-602. PMID: 17621606, DOI: 10.1259/bjr/20129205.Peer-Reviewed Original ResearchConceptsRenal cell carcinomaRenal disordersPapillary renal cell carcinomaAutosomal recessive polycystic kidney diseaseChromophobe renal cell carcinomaRecessive polycystic kidney diseaseRenin-secreting tumorMedullary collecting ductsCell of originPolycystic kidney diseaseHistopathological featuresDuct carcinomaCell carcinomaKidney diseaseMedullary carcinomaJuxtaglomerular cellsSegmental involvementClear cellsProximal tubulesRenal papillaCollecting ductsNephron disordersSegmental disorderCarcinomaDisorders